EUVIMEDSkopri EUVIMED
Crossref

KL‐12 Peptide Targets Peri‐Implantitis via Dual Antibacterial and Immunomodulatory Effects

Jiahao Qin iD, Shuwei Yang, Weixu Meng, Zanxun Zhou, Zihui Yu, Xi Zhang

Oral Diseases · 2025

DOI: 10.1111/odi.15401 ↗

At a glance

Journal article in Oral Diseases, 2025. Written by Jiahao Qin and 5 co-authors. Institution: School and Hospital of Stomatology, Tianjin Medical University, Tianjin, China. Major MEDLINE topics: Peri-Implantitis, Porphyromonas gingivalis, Anti-Bacterial Agents, Antimicrobial Peptides. 48 references. Funded by: National College Students Innovation and Entrepreneurship Training Program.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Aims

Peri‐implantitis is a common dental complication characterized by inflammation of peri‐implant tissues and progressive bone loss. With the rise of antibiotic resistance, this study investigates the potential of antimicrobial peptides (AMPs), specifically KL‐12, a novel peptide derived from cecropin B, as an alternative therapeutic strategy against Porphyromonas gingivalis , a key pathogen in peri‐implantitis.

Methods

We evaluated the structural stability, antibacterial efficacy, and cytotoxicity of KL‐12. Antibacterial activity was measured against P. gingivalis , while the peptide's mode of action was explored concerning its effect on the gingipain proteases essential for the bacterium's nutrient acquisition. Additionally, we assessed KL‐12's impact on macrophage polarization and anti‐inflammatory responses.

Results

The findings revealed that KL‐12 exhibited significant antibacterial activity against P. gingivalis and demonstrated potential as a specific inhibitor of gingipains. It was observed that KL‐12 disrupts bacterial viability through mechanisms involving deformation and nutrient deprivation, rather than traditional pore formation. KL‐12 effectively modulated macrophage polarization, promoting M2 differentiation and enhancing anti‐inflammatory responses.

Conclusion

These results suggest that KL‐12 functions as a dual‐action therapeutic agent, targeting both bacterial pathogens and inflammatory processes in the management of peri‐implantitis. Future studies will aim to clarify the molecular mechanisms underlying KL‐12's antibacterial and immunomodulatory effects.

Subjects

MeSH terms (MEDLINE)

Peri-ImplantitisPorphyromonas gingivalisAnti-Bacterial AgentsAntimicrobial PeptidesImmunologic FactorsGingipain Cysteine EndopeptidasesMacrophagesMiceHumansAnimals

Author keywords

KL‐12antimicrobial peptidesbiofilm inhibitionmacrophage polarizationperi‐implantitis

Substances

Anti-Bacterial AgentsGingipain Cysteine EndopeptidasesAntimicrobial PeptidesImmunologic Factors

Authors and institutions

  • School and Hospital of Stomatology, Tianjin Medical University, Tianjin, China.
  • School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.

ORCID profiles: Jiahao Qin

Funding

  • National College Students Innovation and Entrepreneurship Training Program

Cite

APA

Qin, J., Yang, S., Meng, W., Zhou, Z., Yu, Z., & Zhang, X. (2025). KL‐12 Peptide Targets Peri‐Implantitis via Dual Antibacterial and Immunomodulatory Effects. Oral Diseases. https://doi.org/10.1111/odi.15401

Vancouver

Qin J, Yang S, Meng W, Zhou Z, Yu Z, Zhang X. KL‐12 Peptide Targets Peri‐Implantitis via Dual Antibacterial and Immunomodulatory Effects. Oral Diseases. 2025. doi:10.1111/odi.15401

BibTeX
@article{Qin2025,
  author = {Qin, Jiahao and Yang, Shuwei and Meng, Weixu and Zhou, Zanxun and Yu, Zihui and Zhang, Xi},
  title = {KL‐12 Peptide Targets Peri‐Implantitis via Dual Antibacterial and Immunomodulatory Effects},
  journal = {Oral Diseases},
  year = {2025},
  doi = {10.1111/odi.15401}
}
Start for free →